Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PreventiPlaque - Digital Secondary Prevention in Cardiovascular Disease to Improve Therapy Adherence

NCT05096637 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT05096637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PreventiPlaque - Digital Secondary Prevention in Cardiovascular Disease to Improve Therapy Adherence
Lead sponsor
University Hospital, Essen
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2021
Completion date
July 31, 2023
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic plaque